Clinical Trial Update: Aspirin Dose and Atherosclerosis in Patients With Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating aspirin dose effects on atherosclerosis progression in patients with heart disease has completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Myocardial Infarction

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Cardiovascular Diseases, Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2012-06-18